D |
2024-11-18 |
|
CAVA GROUP, INC. |
4 |
S-Sale |
--D |
8000000.0000 |
9507990.0000 |
1 |
0001639438 |
Common Stock |
D |
2024-08-26 |
|
CAVA GROUP, INC. |
4 |
S-Sale |
--D |
6000000.0000 |
17507990.0000 |
1 |
0001639438 |
Common Stock |
D |
2024-06-05 |
|
CAVA GROUP, INC. |
4 |
S-Sale |
--D |
3000000.0000 |
23507990.0000 |
1 |
0001639438 |
Common Stock |
A |
2024-05-10 |
|
LEXICON PHARMACEUTICALS, INC. |
4 |
A-Award |
--I |
1150922.0000 |
1150922.0000 |
4 |
0001062822 |
Series A Convertible Preferred Stock |
D |
2024-05-10 |
|
LEXICON PHARMACEUTICALS, INC. |
4 |
M-Exempt |
--I |
1150922.0000 |
0.0000 |
5 |
0001062822 |
Series A Convertible Preferred Stock |
A |
2024-05-10 |
|
LEXICON PHARMACEUTICALS, INC. |
4 |
M-Exempt |
--I |
57546100.0000 |
136180481.0000 |
1 |
0001062822 |
Common Stock |
D |
2024-03-21 |
|
CAVA GROUP, INC. |
4 |
S-Sale |
--D |
2000000.0000 |
26507990.0000 |
1 |
0001639438 |
Common Stock |
A |
2024-03-13 |
|
LEXICON PHARMACEUTICALS, INC. |
4 |
A-Award |
--I |
1150922.0000 |
1150922.0000 |
1 |
0001062822 |
Series A Convertible Preferred Stock |
D |
2024-02-27 |
|
CAVA GROUP, INC. |
4 |
S-Sale |
--D |
3500000.0000 |
28507990.0000 |
1 |
0001639438 |
Common Stock |
A |
2023-06-20 |
|
CAVA GROUP, INC. |
4 |
M-Exempt |
--D |
1845864.0000 |
6901095.0000 |
3 |
0001639438 |
Common Stock |
D |
2023-06-20 |
|
CAVA GROUP, INC. |
4 |
M-Exempt |
--D |
1993092.0000 |
0.0000 |
12 |
0001639438 |
Series F Preferred Stock |
D |
2023-06-20 |
|
CAVA GROUP, INC. |
4 |
M-Exempt |
--D |
22252464.0000 |
0.0000 |
11 |
0001639438 |
Series E Preferred Stock |
D |
2023-06-20 |
|
CAVA GROUP, INC. |
4 |
M-Exempt |
--D |
861339.0000 |
0.0000 |
10 |
0001639438 |
Series D Preferred Stock |
D |
2023-06-20 |
|
CAVA GROUP, INC. |
4 |
M-Exempt |
--D |
1845864.0000 |
0.0000 |
9 |
0001639438 |
Series C Preferred Stock |
D |
2023-06-20 |
|
CAVA GROUP, INC. |
4 |
M-Exempt |
--D |
3486366.0000 |
0.0000 |
8 |
0001639438 |
Series B Preferred Stock |
D |
2023-06-20 |
|
CAVA GROUP, INC. |
4 |
M-Exempt |
--D |
1568865.0000 |
0.0000 |
7 |
0001639438 |
Series A Preferred Stock |
A |
2023-06-20 |
|
CAVA GROUP, INC. |
4 |
M-Exempt |
--D |
1993092.0000 |
32007990.0000 |
6 |
0001639438 |
Common Stock |
A |
2023-06-20 |
|
CAVA GROUP, INC. |
4 |
M-Exempt |
--D |
22252464.0000 |
30014898.0000 |
5 |
0001639438 |
Common Stock |
A |
2023-06-20 |
|
CAVA GROUP, INC. |
4 |
M-Exempt |
--D |
861339.0000 |
7762434.0000 |
4 |
0001639438 |
Common Stock |
A |
2023-06-20 |
|
CAVA GROUP, INC. |
4 |
M-Exempt |
--D |
3486366.0000 |
5055231.0000 |
2 |
0001639438 |
Common Stock |
A |
2023-06-20 |
|
CAVA GROUP, INC. |
4 |
M-Exempt |
--D |
1568865.0000 |
1568865.0000 |
1 |
0001639438 |
Common Stock |
A |
2023-06-05 |
|
LEXICON PHARMACEUTICALS, INC. |
4 |
P-Purchase |
--I |
27775050.0000 |
78634381.0000 |
1 |
0001062822 |
Common Stock |
A |
2022-08-05 |
|
LEXICON PHARMACEUTICALS, INC. |
4 |
P-Purchase |
--I |
2426070.0000 |
50859331.0000 |
1 |
0001062822 |
Common Stock |
A |
2022-08-01 |
|
LEXICON PHARMACEUTICALS, INC. |
4 |
P-Purchase |
--I |
16173800.0000 |
48433261.0000 |
1 |
0001062822 |
Common Stock |
A |
2020-12-16 |
|
LEXICON PHARMACEUTICALS, INC. |
4 |
P-Purchase |
--I |
10937500.0000 |
32259461.0000 |
1 |
0001062822 |
Common Stock |
A |
2018-05-29 |
|
Scholar Rock Holding Corp |
4 |
C-Conversion |
--D |
1946040.0000 |
1946040.0000 |
1 |
0001727196 |
Common Stock |
A |
2018-05-29 |
|
Scholar Rock Holding Corp |
4 |
P-Purchase |
--I |
450000.0000 |
450000.0000 |
2 |
0001727196 |
Common Stock |
D |
2018-05-29 |
|
Scholar Rock Holding Corp |
4 |
C-Conversion |
--D |
5555556.0000 |
0.0000 |
3 |
0001727196 |
Series C Preferred Stock |
A |
2014-11-26 |
|
LEXICON PHARMACEUTICALS, INC./DE |
4 |
P-Purchase |
--I |
149253731.0000 |
149253731.0000 |
1 |
0001062822 |
Common Stock |
A |
2012-10-23 |
|
LEXICON PHARMACEUTICALS, INC./DE |
4 |
P-Purchase |
--I |
3000000.0000 |
283154744.0000 |
1 |
0001062822 |
Common Stock |
- |
- |
|
Scholar Rock Holding Corp |
3 |
- |
--D |
|
|
1 |
0001727196 |
Series C Preferred Stock |
- |
- |
|
LEXICON PHARMACEUTICALS, INC./DE |
3 |
- |
--I |
|
250372135.0000 |
1 |
0001062822 |
Common Stock |
- |
- |
|
LEXICON PHARMACEUTICALS, INC./DE |
4 |
- |
--I |
|
247818843.0000 |
2 |
0001062822 |
Common Stock |
- |
- |
|
LEXICON PHARMACEUTICALS, INC./DE |
4 |
- |
--I |
|
5553292.0000 |
3 |
0001062822 |
Common Stock |
- |
- |
|
LEXICON PHARMACEUTICALS, INC. |
4 |
- |
--I |
|
35402689.0000 |
3 |
0001062822 |
Common Stock |
- |
- |
|
LEXICON PHARMACEUTICALS, INC. |
4 |
- |
--I |
|
3516214.0000 |
2 |
0001062822 |
Common Stock |
- |
- |
|
CAVA GROUP, INC. |
3 |
- |
--D |
|
|
6 |
0001639438 |
Series F Preferred Stock |
- |
- |
|
CAVA GROUP, INC. |
3 |
- |
--D |
|
|
5 |
0001639438 |
Series E Preferred Stock |
- |
- |
|
CAVA GROUP, INC. |
3 |
- |
--D |
|
|
4 |
0001639438 |
Series D Preferred Stock |
- |
- |
|
CAVA GROUP, INC. |
3 |
- |
--D |
|
|
3 |
0001639438 |
Series C Preferred Stock |
- |
- |
|
CAVA GROUP, INC. |
3 |
- |
--D |
|
|
2 |
0001639438 |
Series B Preferred Stock |
- |
- |
|
CAVA GROUP, INC. |
3 |
- |
--D |
|
|
1 |
0001639438 |
Series A Preferred Stock |
- |
- |
|
LEXICON PHARMACEUTICALS, INC. |
4 |
- |
--I |
|
35402689.0000 |
3 |
0001062822 |
Common Stock |
- |
- |
|
LEXICON PHARMACEUTICALS, INC. |
4 |
- |
--I |
|
3516214.0000 |
2 |
0001062822 |
Common Stock |
- |
- |
|
LEXICON PHARMACEUTICALS, INC. |
4 |
- |
--I |
|
35402689.0000 |
3 |
0001062822 |
Common Stock |
- |
- |
|
LEXICON PHARMACEUTICALS, INC. |
4 |
- |
--I |
|
3516214.0000 |
2 |
0001062822 |
Common Stock |
- |
- |
|
LEXICON PHARMACEUTICALS, INC. |
4 |
- |
--I |
|
35402689.0000 |
3 |
0001062822 |
Common Stock |
- |
- |
|
LEXICON PHARMACEUTICALS, INC. |
4 |
- |
--I |
|
3516214.0000 |
2 |
0001062822 |
Common Stock |
- |
- |
|
LEXICON PHARMACEUTICALS, INC. |
4 |
- |
--I |
|
35402689.0000 |
3 |
0001062822 |
Common Stock |
- |
- |
|
LEXICON PHARMACEUTICALS, INC. |
4 |
- |
--I |
|
3516214.0000 |
2 |
0001062822 |
Common Stock |